Tag Archives: Antineoplaston

Dr. Burzynski Updates

Dear Burzynski Movie subscribers, Hello from England! My last newsletter was in late July, sharing with you the good news about a London, England area patient named Hannah Bradley, who was diagnosed last year with a deadly brain tumor—known as an … Continue reading

| Tagged , , , , ,

Burzynski Updates :Cancer Is Serious Business

January 11, 2012 Dear Burzynski Movie subscribers, We won the audience award for “Best Doc of 2011″ on The Documentary Channel! A big thank you to everyone who voted! We won the audience award for Best Documentary of 2011 on … Continue reading

| Tagged , ,

Response to the White House Petition 2011

December 20, 2011 I have received a lot of emails expressing confusion about the White House’s “response” to our petition. I thought I’d outline their underhanded strategy for you in this article. My petition to the White House [1] was … Continue reading

| Tagged , , , ,

Antineoplastons, cancer drugs in FDA trials since 1995, results publicly audited by Congress, to gain final FDA-approval

 I am highlighting this Petition and ask for your support for this life-giving medical breakthrough. Antineoplastons are gene-targeted cancer medications that have completed Phase 2 FDA clinical trials in 2009, with permission granted to enter the final Phase of FDA … Continue reading

| Tagged , , , , , | 2 Comments

Burzynski Movie Subscribers

July 21, 2011 Dear Burzynski Movie Subscribers, We have some exciting news—as well as some rather disturbing news to announce. First, the exciting news: 1 . USA Television Premiere of Burzynski, the Movie: Cancer Is Serious Business on The Documentary … Continue reading

| Tagged , , , , , , | 1 Comment

Dr. Burzynski :Cancer Is Serious Business

This shocking information was sent into us this morning by Chris Whilst shocking it is also an example of the truth coming out despite the best efforts of vested interests. Hi Chris, I have highlighted this before about 2years ago and I am … Continue reading

| Tagged , , , , , , | 1 Comment